Clinical Trial Update: Comparison Between Retrolaminar and Medial Branch Block in Cervical Facet Joint Arthropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing retrolaminar versus medial branch block for cervical facet joint arthropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Facet Joint Arthropathy
• Joint Pain

Snippet

Sponsor: Mansoura University | Conditions: Joint Pain | Phase 2 | Status: COMPLETED